[go: up one dir, main page]

DK1344533T3 - Farmaceutiske præparater, der omfatter mannosebindende lectin - Google Patents

Farmaceutiske præparater, der omfatter mannosebindende lectin

Info

Publication number
DK1344533T3
DK1344533T3 DK03388016T DK03388016T DK1344533T3 DK 1344533 T3 DK1344533 T3 DK 1344533T3 DK 03388016 T DK03388016 T DK 03388016T DK 03388016 T DK03388016 T DK 03388016T DK 1344533 T3 DK1344533 T3 DK 1344533T3
Authority
DK
Denmark
Prior art keywords
mbl
pharmaceutical compositions
binding lectin
compositions
variants
Prior art date
Application number
DK03388016T
Other languages
Danish (da)
English (en)
Inventor
Jesper Lund Larsen
Leif Kongerslev
Original Assignee
Natimmune As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Natimmune As filed Critical Natimmune As
Application granted granted Critical
Publication of DK1344533T3 publication Critical patent/DK1344533T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Zoology (AREA)
  • Virology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK03388016T 2002-03-15 2003-03-14 Farmaceutiske præparater, der omfatter mannosebindende lectin DK1344533T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA200200414 2002-03-15
PCT/DK2003/000179 WO2003077937A1 (en) 2002-03-15 2003-03-14 Pharmaceutical compositions comprising mannose binding lectin

Publications (1)

Publication Number Publication Date
DK1344533T3 true DK1344533T3 (da) 2007-01-08

Family

ID=27763313

Family Applications (1)

Application Number Title Priority Date Filing Date
DK03388016T DK1344533T3 (da) 2002-03-15 2003-03-14 Farmaceutiske præparater, der omfatter mannosebindende lectin

Country Status (11)

Country Link
US (1) US7462596B2 (de)
EP (1) EP1344533B1 (de)
JP (1) JP2005526084A (de)
CN (1) CN1652813A (de)
AT (1) ATE337014T1 (de)
AU (1) AU2003215524A1 (de)
DE (1) DE60307701T2 (de)
DK (1) DK1344533T3 (de)
ES (1) ES2271515T3 (de)
PT (1) PT1344533E (de)
WO (1) WO2003077937A1 (de)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030119734A1 (en) 2001-06-28 2003-06-26 Flink James M. Stable formulation of modified GLP-1
GB0222014D0 (en) * 2002-09-23 2002-10-30 Leuven K U Res & Dev Mannan-binding lectin
EP2292254A3 (de) 2003-06-03 2011-12-14 Novo Nordisk A/S Stabilisierte pharmazeutische Peptidzusammensetzungen
JP2007524592A (ja) 2003-06-03 2007-08-30 ノボ・ノルデイスク・エー／エス 安定化された薬学的ペプチド組成物
CN1882356B (zh) 2003-11-20 2015-02-25 诺沃挪第克公司 对于生产和用于注射装置中是最佳的含有丙二醇的肽制剂
US7335633B2 (en) * 2004-01-12 2008-02-26 Cornell Research Foundation, Inc. Detecting recurrent vulvovaginal candidiasis or vulvar vestibulitis syndrome and method for treating same
EP1618887A1 (de) * 2004-07-12 2006-01-25 UMC Utrecht Holding B.V. Beseitigung von Polyolen aus dem Körper
ES2442223T3 (es) 2004-08-31 2014-02-10 Novo Nordisk A/S Uso de tris(hidroximetil) aminometano para la estabilización de péptidos, polipéptidos y proteínas
RU2413530C9 (ru) 2004-11-12 2021-05-18 Ново Нордиск А/С Стабильные препараты инсулинотропных пептидов
WO2006071102A1 (en) * 2004-12-30 2006-07-06 Dobeel Co., Ltd. Spray-dried composition containing collectin family proteins or variants therof and process for preparing the same
US20080214435A1 (en) * 2005-04-11 2008-09-04 Natlmmune A/S Novel Cancer Indications of Mannan-Binding Lectin (Mbl) in the Treatment of Immunocompromised Individuals
TW200727900A (en) * 2005-07-27 2007-08-01 Yakult Honsha Kk Aqueous solution preparation containing camptothecins
EP2004850A2 (de) * 2006-03-08 2008-12-24 Universitair Medisch Centrum Utrecht Stören der aktivierung einer immunzelle durch beeinflussen der wechselwirkung von lair und collagen
JP5701603B2 (ja) * 2007-09-10 2015-04-15 ボストン バイオメディカル， インコーポレイテッド Ｓｔａｔ３経路阻害剤および癌幹細胞経路阻害剤の新規のグループ
GB0821806D0 (en) 2008-11-28 2009-01-07 Circassia Ltd Compositions with reduced dimer formation
BR112012001070B1 (pt) * 2009-07-17 2022-05-03 Omeros Corporation Composição de polipeptídeo associado à ficolina e uso da mesma
AU2011207626B2 (en) 2010-01-19 2015-06-18 President And Fellows Of Harvard College Engineered opsonin for pathogen detection and treatment
FI2547205T3 (fi) 2010-03-19 2024-05-27 1Globe Biomedical Co Ltd Uusia menetelmiä syövän kantasolujen kohdentamiseksi
CA2842321C (en) 2011-07-18 2022-05-03 President And Fellows Of Harvard College Engineered microbe-targeting molecules and uses thereof
EP2820147B1 (de) 2012-02-29 2018-08-08 President and Fellows of Harvard College Schnelltests auf empfindlichkeit gegen antibiotika
LT2861246T (lt) * 2012-06-18 2021-04-26 Omeros Corporation Masp-1 ir (arba) masp-2, ir (arba) masp-3 slopinimo kompozicijos ir būdai, skirti įvairių ligų ir sutrikimų gydymui
EP2976642A4 (de) 2013-03-15 2016-09-21 Harvard College Verfahren und zusammensetzungen zur verbesserung der erkennung und/oder aufnahme einer zieleinheit
WO2014169078A2 (en) 2013-04-09 2014-10-16 Boston Biomedical, Inc. Methods for treating cancer
CA2913155A1 (en) 2013-05-21 2014-11-27 President And Fellows Of Harvard College Engineered heme-binding compositions and uses thereof
EP3546474B1 (de) 2013-12-18 2021-07-07 President and Fellows of Harvard College Crp-erfassung/-detektion von grampositiven bakterien
WO2017024114A1 (en) 2015-08-06 2017-02-09 President And Fellows Of Harvard College Improved microbe-binding molecules and uses thereof
CA3045306A1 (en) 2016-11-29 2018-06-07 Boston Biomedical, Inc. Naphthofuran derivatives, preparation, and methods of use thereof
CA3062656A1 (en) 2017-05-17 2018-11-22 Boston Biomedical, Inc. Methods for treating cancer
MY198425A (en) 2017-08-24 2023-08-29 Novo Nordisk As Glp-1 Compositions and uses Thereof
CN110755601B (zh) * 2019-10-31 2023-06-23 云南康洲生物科技有限公司 一种治疗hiv/aids免疫重建缺陷的芸豆凝集素植物药组合物和制备方法及其应用
US20230082544A1 (en) 2020-02-18 2023-03-16 Novo Nordisk A/S Pharmaceutical formulations

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2272067T3 (es) * 1998-06-10 2007-04-16 Statens Serum Institut Procedimiento de purificacion para la produccion de lecitina de union a manano y un producto medicinal de mbl.
JP4707231B2 (ja) * 1998-06-10 2011-06-22 スタテンズ セーラム インスティテュート マンナン結合レクチンを製造するための精製方法及びｍｂｌ医薬品
US6297024B1 (en) * 1998-10-15 2001-10-02 Cell Activation, Inc. Methods for assessing complement activation
CN1359420A (zh) * 1999-05-14 2002-07-17 斯蒂芬·蒂尔 重组人甘露聚糖结合型凝集素
US7211396B2 (en) * 2002-04-18 2007-05-01 Antibodyshop A/S Antibody pairs and kits for immunochemical determination of mannan-binding lectin

Also Published As

Publication number Publication date
ATE337014T1 (de) 2006-09-15
ES2271515T3 (es) 2007-04-16
EP1344533B1 (de) 2006-08-23
WO2003077937A1 (en) 2003-09-25
DE60307701T2 (de) 2007-10-11
US7462596B2 (en) 2008-12-09
AU2003215524A1 (en) 2003-09-29
US20040006009A1 (en) 2004-01-08
CN1652813A (zh) 2005-08-10
JP2005526084A (ja) 2005-09-02
PT1344533E (pt) 2007-01-31
DE60307701D1 (de) 2006-10-05
EP1344533A1 (de) 2003-09-17

Similar Documents

Publication Publication Date Title
DK1344533T3 (da) Farmaceutiske præparater, der omfatter mannosebindende lectin
IL203923A (en) Benzamide compounds, pharmaceutical compositions comprising them, use thereof in the preparation of medicaments and as medicaments and processes for the preparation of such compounds
BR9914360A (pt) N-aralquilaminotetralinas como ligandos para oreceptor neuropeptìdeo yy5
MY106315A (en) Pharmaceutical agents
EA200800056A1 (ru) Каннабиноидный активный фармацевтический ингредиент для лекарственных форм
PL372809A1 (en) Substituted 1,3-diphenylprop-2-en-1-one derivatives and preparation and uses thereof
BR0311313A (pt) Derivados de diaril uréia úteis para o tratamento de doenças dependentes de proteìna cinase
NO20064347L (no) Substituerte 1,2,3,4-tetrahydroisokinolinderivater
NO20042298L (no) Farmasoytiske preparater og deres anvendelser
NO20003698L (no) Orale sammensetninger
BR0210711A (pt) Uso de um composto, composição farmacêutica, composto, e, processo para a preparação de um composto
CA2534798A1 (en) Thiazole derivatives as cannabinoid receptor modulators
BRPI0113286B8 (pt) pirazóis substituídos e composição farmacêutica compreendendo os mesmos.
BR9910583A (pt) Aminotetralinas n-substituìdas como ligantes para o receptor de neuropeptìdeo y y5 úteis no tratamento de obesidade e outros distúrbios
CY1107470T1 (el) Συνθεσεις γλυκοσυλιωμενης λεπτινης και σχετικες μεθοδοι
BR0112962B1 (pt) Composições farmacêuticas compreendendo ácido hialurônico, ácido glicirretínico e polivinilpirrolidona, e uso desses compostos na preparação de medicamentos
DK0733046T3 (da) Benzoylguanidiner, deres fremstilling og anvendelse i medikamenter
CL2004000930A1 (es) Compuesto derivado de dihidroquinazolina de formula definida, util para el tratamiento y/o profilaxis de infecciones virales; composicion farmaceutica que comprende al compuesto y uso del compuesto en la preparacion de medicamentos.
BR0210122A (pt) Composto ou um sal farmaceuticamente aceitável do mesmo, método para o tratamento ou prevenção de uma doença, uso do composto ou de seu sal, e, método para preparar o mesmo
BRPI0412871A (pt) combinações de substáncias ativas fungicidas
BR0212075A (pt) Combinações de substâncias ativas fungicidas
ATE549353T1 (de) Aktive varianten des il-18 bindenden proteins und dessen medizinische verwendungen
PT1057828E (pt) Suspensoes de trovafloxacina para administracao oral
DK1651270T3 (da) Medikamenter til inhalation omfattende betamimetika og et anticholinergikum
WO2003050067A3 (fr) Analogues de la vitamine d